Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Roussou

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Bortezomib in multiple myelomaEvangelos Terpos, Maria Roussou, Meletios-Athanassios Dimopoulos
Urology|March 18, 2008
Wegener's granulomatosis presenting as a renal massMaria Roussou, Stavros K Dimopoulos, Meletios A Dimopoulos, et al.
IEEE Transactions on Visualization and Computer Graphics|April 7, 2023
Comparing Different Grasping Visualizations for Object Manipulation in VR using ControllersGiorgos Ganias, Christos Lougiakis, Akrivi Katifori, et al.
Expert Opinion on Biological Therapy|April 7, 2009
RANKL inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastasesEvangelos Terpos, Eleni Efstathiou, Dimitrios Christoulas, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2017
Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myelomaAntonios Bilalis, Evi Pouliou, Maria Roussou, et al.
Leukemia & Lymphoma|April 25, 2007
Pulsed cyclophosphamide, thalidomide and dexamethasone regimen for previously treated patients with multiple myeloma: long term follow up and disease control after subsequent treatmentsMaria Roussou, Athanasios Anagnostopoulos, Efstathios Kastritis, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Rituximab-based treatments in Waldenström's macroglobulinemiaMeletios A Dimopoulos, Efstathios Kastritis, Maria Roussou, et al.
Leukemia & Lymphoma|May 9, 2008
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimensMaria Roussou, Efstathios Kastritis, Magdalini Migkou, et al.
Leukemia Research|June 1, 2010
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agentsMaria Roussou, Efstathios Kastritis, Dimitrios Christoulas, et al.
Leukemia & Lymphoma|December 7, 2011
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimensEvangelos Eleftherakis-Papapiakovou, Esftathios Kastritis, Maria Roussou, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Bortezomib in multiple myelomaEvangelos Terpos, Maria Roussou, Meletios-Athanassios Dimopoulos
Urology|March 18, 2008
Wegener's granulomatosis presenting as a renal massMaria Roussou, Stavros K Dimopoulos, Meletios A Dimopoulos, et al.
IEEE Transactions on Visualization and Computer Graphics|April 7, 2023
Comparing Different Grasping Visualizations for Object Manipulation in VR using ControllersGiorgos Ganias, Christos Lougiakis, Akrivi Katifori, et al.
Expert Opinion on Biological Therapy|April 7, 2009
RANKL inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastasesEvangelos Terpos, Eleni Efstathiou, Dimitrios Christoulas, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2017
Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myelomaAntonios Bilalis, Evi Pouliou, Maria Roussou, et al.
Leukemia & Lymphoma|April 25, 2007
Pulsed cyclophosphamide, thalidomide and dexamethasone regimen for previously treated patients with multiple myeloma: long term follow up and disease control after subsequent treatmentsMaria Roussou, Athanasios Anagnostopoulos, Efstathios Kastritis, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Rituximab-based treatments in Waldenström's macroglobulinemiaMeletios A Dimopoulos, Efstathios Kastritis, Maria Roussou, et al.
Leukemia & Lymphoma|May 9, 2008
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimensMaria Roussou, Efstathios Kastritis, Magdalini Migkou, et al.
Leukemia Research|June 1, 2010
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agentsMaria Roussou, Efstathios Kastritis, Dimitrios Christoulas, et al.
Leukemia & Lymphoma|December 7, 2011
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimensEvangelos Eleftherakis-Papapiakovou, Esftathios Kastritis, Maria Roussou, et al.
Pageof 8